Alpine Competitors and Similar CompaniesClear all

ARTPred's competitors and similar companies include Kymab, Alcresta and Gobiquity.
ARTPred
ARTPred
ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling.
Kymab
Kymab
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
Alcresta
Alcresta
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
Gobiquity
Gobiquity
Gobiquity, Inc. (formerly ICHECK Health Connection, Inc.) provides mobile applications for the early detection and tracking of eye diseases in the United States
Founding Date
Founding Date
2014
Founding Date
2009
Founding Date
2011
Founding Date
2011
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
's-Hertogenbosch, NL HQ
Locations
Cambridge, GB HQ
Locations
Newton, US HQ
Locations
Portland, US HQ
Employees
Employees
5
Employees
407% decrease
Employees
82
Employees
455% increase

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 100m (over 9 years ago)
Latest funding round
$ 60m (over 8 years ago)
Latest funding round
$ 6m (almost 10 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 220.4m
Total funding raised
$ 139.4m
Total funding raised
$ 6.8m
For sources of this data, please see the company profile

View Company Profiles

Kymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease

Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.

View company
Alcresta
HQ
Newton, US
Employees
82

Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.

View company
Gobiquity
HQ
Portland, US
Employees
45↑ 5% increase

Gobiquity, Inc. (formerly ICHECK Health Connection, Inc.) provides mobile applications for the early detection and tracking of eye diseases in the United States

View company